6533b859fe1ef96bd12b6eea
RESEARCH PRODUCT
Failure of Cytomegalovirus-Specific CD8+ T Cell Levels at Viral DNAemia Onset to Predict the Eventual Need for Preemptive Antiviral Therapy in Allogeneic Hematopoietic Stem Cell Transplant Recipients
Paula AmatEstela GiménezJuan Carlos Hernández-boludaCarlos SolanoCarlos SolanoMaría José RemigiaJosé Luis PiñanaEva M. MateoMarc PochEliseo AlbertAriadna PérezDavid Navarrosubject
Enzyme-Linked Immunospot Assaymedicine.medical_treatmentCongenital cytomegalovirus infectionCytomegalovirusHematopoietic stem cell transplantationCD8-Positive T-Lymphocytes030230 surgeryAntiviral Agents03 medical and health sciences0302 clinical medicineCorrespondencemedicineHumansImmunology and AllergyCytotoxic T cellbusiness.industryHematopoietic Stem Cell TransplantationAntiviral therapyCmv dnaemiamedicine.diseaseTransplant RecipientsInfectious DiseasesCytomegalovirus InfectionsImmunology030211 gastroenterology & hepatologyCytomegalovirus infectionsAllogeneic hematopoietic stem cell transplantEnzyme linked immunospot assaybusinessyear | journal | country | edition | language |
---|---|---|---|---|
2018-11-22 | The Journal of Infectious Diseases |